{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:40:37Z","timestamp":1790426437385,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.cancergencyto.2009.02.018","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T08:49:34Z","timestamp":1243500574000},"page":"40-43","source":"Crossref","is-referenced-by-count":15,"title":["Association of MLL amplification with poor outcome in acute myeloid leukemia"],"prefix":"10.1016","volume":"192","author":[{"given":"Robert W.","family":"Maitta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.02.018_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/gcc.20288","article-title":"Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study","volume":"45","author":"Tyyb\u00e4kinoja","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/sj.leu.2403535","article-title":"Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2","volume":"18","author":"Vazquez","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molmed.2004.08.005","article-title":"MLL: a histone methyltransferase disrupted in leukemia","volume":"10","author":"Hess","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib4","first-page":"350","article-title":"ALL1 gene alterations in acute leukemia: biological and clinical aspects","volume":"83","author":"Cimino","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","article-title":"The MLL partial tandem duplication in acute myeloid leukemia","volume":"135","author":"Basecke","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2401919","article-title":"MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study","volume":"14","author":"Cuthbert","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib7","article-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1003>3.3.CO;2-L","article-title":"MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23","volume":"29","author":"Michaux","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00602-1","article-title":"MLL amplification in myeloid malignancies: clinical, molecular, and cytogenetic findings","volume":"134","author":"Dolan","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cancergencyto.2006.11.019","article-title":"MLL amplification in acute myeloid leukemia","volume":"174","author":"Pajuelo-G\u00e1mez","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1365-2141.2003.04493.x","article-title":"Chromosome 11 rearrangements and specific MLL amplification revealed by spectral karyotyping in a patient with refractory anemia with excess of blasts (RAEB)","volume":"122","author":"Calabrese","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2003-06-2163","article-title":"Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies","volume":"103","author":"Poppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.1115","volume":"31","author":"Andersen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexmp.2005.05.007","article-title":"Oncogene amplification in transforming myelodysplasia","volume":"79","author":"Papenhausen","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cancergencyto.2009.02.018_bib15","series-title":"chromosomal and molecular genetic aberrations of tumor cells","first-page":"69","article-title":"Acute myeloid leukemias","author":"Heim","year":"1995"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809001368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T09:21:11Z","timestamp":1545211271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0165460809001368"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.02.018","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}